FDA now requires testosterone products to have blood clot risk warning on labels

June 21, 2014 11:56 AM

11 0

FDA now requires testosterone products to have blood clot risk warning on labels

Manufacturers of testosterone products are now required to include a general warning on labels to inform users of blood clot risks. FDA's investigation on stroke, heart attack and death risks linked with testosterone therapy is currently ongoing.(Photo : U.S. Drug Enforcement Administration)

Manufacturers of testosterone products are now required to include a general warning on labels to inform users of blood clot risks. FDA's investigation on stroke, heart attack and death risks linked with testosterone therapy is currently ongoing.

Also read: The Latest: Student's death 'touches the American heart'

Read more

To category page

Loading...